14.01.2015 Views

Vol 41 # 3 September 2009 - Kma.org.kw

Vol 41 # 3 September 2009 - Kma.org.kw

Vol 41 # 3 September 2009 - Kma.org.kw

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

274<br />

WHO-Facts Sheet <strong>September</strong> <strong>2009</strong><br />

membership now represents 99 percent of the<br />

world’s population. “Applying Codex standards and<br />

guidelines are an important part of ensuring that<br />

consumers in every part of the world can be protected<br />

from unsafe food,” he said.<br />

The Commission also launched new work projects,<br />

among them establishing maximum levels for<br />

melamine in food and feed. In the last few years, high<br />

levels of melamine have been added illegally to food<br />

and feed products, causing illness and death. Because<br />

it has many industrial uses, melamine may be found<br />

in trace amounts in the food chain due to its presence<br />

in the environment. Setting maximum limits will<br />

help governments differentiate between unavoidable<br />

melamine occurrence and the deliberate adulteration<br />

of food and feed.<br />

Other new work proposals adopted by the<br />

Commission include:<br />

• Principles and guidelines to assist governments in<br />

the development and operation of comprehensive<br />

national food control systems that protect the<br />

health of consumers and ensure fair practices in the<br />

food trade;<br />

• Practices to control viruses in food, especially<br />

norovirues (NoV) and hepatitis A (HAV) in fresh<br />

produce, mulluscan shell fish and ready-to-eat<br />

foods;<br />

• Prevention of aflatoxin (toxic substances produced<br />

by moulds and known to cause cancer in animals)<br />

contamination of Brazil nuts.<br />

• Setting maximum levels and defining sampling<br />

plans for Fumonisins, (toxic substances produced<br />

by fungi) in maize and maize products.<br />

For more information contact:<br />

Sari Setiogi, Media Relations Officer, Health Security and<br />

the Environment, WHO, Geneva<br />

Mobile: +<strong>41</strong> 79 701 9467 Tel: +<strong>41</strong> 22 791 3576,<br />

Email: setiogis@who.int<br />

Steven Cohen, Media Relations Officer, Codex Secretariat,<br />

Rome, Italy, Tel. direct: +39 06 570 55283, Mobile: +39<br />

339 627 7627, E-mail: steven.cohen@fao.<strong>org</strong><br />

3. INFECTION PREVENTION AND CONTROL IN<br />

HEALTH CARE FOR CONFIRMED OR SUSPECTED<br />

A(H1N1) SWINE INFLUENZA PATIENTS<br />

Background<br />

The current situation regarding the outbreaks of<br />

A(H1N1) swine influenza is evolving rapidly, and<br />

countries from different regions of the globe have been<br />

affected.<br />

Based on epidemiological data, human-to-human<br />

transmission has been demonstrated along with the<br />

ability of the virus to cause community-level outbreaks<br />

which together suggest the possibility of sustained<br />

human-to-human transmission. Health-care facilities<br />

now face the challenge of providing care for patients<br />

infected with A(H1N1) swine influenza. It is critical<br />

that health-care workers use appropriate infection<br />

control precautions when caring for patients with<br />

influenza-like symptoms, particularly in areas affected<br />

by outbreaks of A(H1N1) swine influenza, in order<br />

to minimize the possibility of transmission among<br />

themselves, to other health-care workers, patients and<br />

visitors.<br />

As at 29 April, human-to-human transmission of<br />

A(H1N1) swine influenza virus appears to be mainly<br />

through droplets. Therefore, the infection control<br />

precautions for patients with suspected or confirmed<br />

A(H1N1) swine influenza and those with influenza-like<br />

symptoms should prioritize the control of the spread<br />

of respiratory droplets. The precautions for influenza<br />

virus with sustained human-to-human transmission<br />

(e.g., pandemic-prone influenza) are described in detail<br />

in the document “Infection prevention and control<br />

of epidemic- and pandemic-prone acute respiratory<br />

diseases in health care WHO Interim Guidelines”<br />

(Available at http://www.who.int/csr/resources/<br />

publications/WHO_CD_EPR_2007_6/en/index.<br />

html). This guidance may change as new information<br />

becomes available.<br />

Fundamentals of infection prevention strategies<br />

1. Administrative controls are key components,<br />

including: implementation of Standard and<br />

Droplet Precautions; avoid crowding, promote<br />

distance between patients (≥ 1 m); patient triage for<br />

early detection, patient placement and reporting;<br />

<strong>org</strong>anization of services; policies on rational use of<br />

available supplies; policies on patient procedures;<br />

strengthening of infection control infrastructure.<br />

2. Environmental/engineering controls, such as<br />

basic health-care facility infrastructure, adequate<br />

ventilation, proper patient placement, and adequate<br />

environmental cleaning can help reduce the spread<br />

of some respiratory pathogens during health care.<br />

3. Rational use of available personal protective<br />

equipment (PPE) and appropriate hand hygiene.<br />

Critical Measures:<br />

• Avoid crowding patients together, promote distance<br />

between patients<br />

• Protect mucosa of mouth and nose<br />

• Perform hand hygiene<br />

SUMMARY PRECAUTIONS<br />

For staff providing care to patients with suspected<br />

or confirmed A(H1N1) swine influenza infection and<br />

for patients with influenza-like symptoms:

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!